On Tuesday, Shares of JD.Com Inc (ADR) (NASDAQ:JD), lost -6.30% to $26.91. The stock attained the volume of 13.94 million shares.
JD.com, Inc. (JD), China’s largest online direct sales company, recently declared the opening of its first U.S. facility, a new research and development center located in Silicon Valley. Dedicated yesterday in Santa Clara, the new office will focus on developing and enhancing new and existing technologies that will improve the user experience for its customers in China and boost the company’s offerings.
The new facility will also allow easier interactions between the company and U.S. retailers, partners and brands seeking to establish or expand their presence in China on JD’s shopping platforms.
The weekend dedication ceremony was hosted by members of the JD.com leadership team, counting Rain Long, chief human resources officer and general counsel; Chen Zhang, senior vice president of JD.com and head of R&D for JD Mall; and Dennis Weng, chief technical advisor for JD Mall. The event was also attended by representatives from a number of leading Silicon Valley tech companies counting Intel, ZestFinance, Mellanox and Wish.
JD.com, Inc., through its auxiliaries, operates as an online direct sales company in the People’s Republic of China. It primarily offers electronics and home appliances products; and general merchandise products, counting audio and video products, and books. The company sells its products directly to customers through its Website jd.com and mobile applications.
At the end of Tuesday’s trade, Shares of Infosys Ltd ADR (NYSE:INFY), declined -1.96% to $17.53.
Infosys (INFY), a global leader in consulting, technology, outsourcing and next-generation services, has been inducted into the ‘Winner’s Circle’ in the inaugural HfS IoT Services Blueprint report 2015 by leading analyst firm HfS Research. Companies that demonstrate excellence in execution and innovation are placed in the ‘Winner’s Circle’ by HfS.
Highlights:
The engineering services unit of Infosys spearheads the company’s IoT activities. This has been commended by HfS in the report
HfS notes investments made by Infosys across the entire IoT ecosystem creating repeatable IP, working in partnership with the Industrial Internet Consortium and supporting Industry 4.0
The report commends Infosys for understanding the criticality of security in IoT, and highlights the company’s strong capabilities across the IoT stack
The company’s ability to stay focused on projects and turn vision into reality in such a dynamic and complex environment was listed as a key strength
Infosys was called out for its employees being able to blend seamlessly into their clients’ culture, and for assisting them make decisions, much like internal associates
Infosys Limited, together with its auxiliaries, provides business consulting, technology, engineering, and outsourcing services in North America, Europe, India, and internationally.
Finally, Shares of Bristol-Myers Squibb Co (NYSE:BMY), ended its last trade with -0.59% loss, and closed at $62.34.
Bristol-Myers Squibb declared that more than 50,000 virtual flags have been raised by Americans across the country as part of the Ready. Raise. Rise. campaign, a program dedicated to raising awareness and educating the public about an exciting area of cancer research called Immuno-Oncology. Twenty-three cancer advocacy organizations took part with Bristol-Myers Squibb, together with two-time Emmy® award-winning actor Eric Stonestreet, of television’s hit comedy “Modern Family,” to launch Ready. Raise. Rise. in May.
The campaign encouraged people to visit ReadyRaiseRise.com to create a personalized, virtual flag to honor a loved one touched by cancer. Visitors could share the personalized flag on social media using the hashtag #RaiseYourFlag, and select a cancer advocacy organization they wished to support from among 23 participating groups. The more than 50,000 flags that have been raised as part of the campaign have assisted generate raised attention to the field of Immuno-Oncology, an area of research that aims to harness the body’s own immune system to assist fight cancer. Education about Immuno-Oncology research is needed, as a survey that was conducted preceding to the launch of the campaign found that only 15 percent of Americans were knowledgeable about this area of science.
As part of the campaign, three organizations among the 23 groups have received a charitable donation from Bristol-Myers Squibb for having the most flags raised on their behalf. Chris4Life Colon Cancer Foundation, Cancer Support Community and CancerCare had a combined total of 40,862 flags raised in their name, and have received a donation of $75,000, $50,000 and $25,000, respectively.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, counting virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
